Hospitals are racing to cut deals to sell their data - and those able to package it and find the right partners quick enough could find themselves with a substantial market advantage.
The Spanish government has put forward a draft bill to strengthen its NHS system, and wean it off the private sector. A well-placed source at HBI 2022 tells us that for-profits are so entrenched and vital to Spain's NHS system that attempts to remove them would be too catastrophic, meaning a wholesale removal is highly unlikely. The bill still needs to pass the legislature before it becomes law.
At the HealthTech Summit in London, Ali Parsa, CEO of US-listed-telehealth group Babylon, clashed with Kevin Ryan, CEO of New York investment fund AlleyCorp, over the level of threat the current economic climate poses to digital health companies.
Metropolis Healthcare, the big Indian diagnostic and pathology group, is determined to forestall potential predators despite talk of a $1bn joint bid from hospital chain Apollo and conglomerate Adani Group.
Despite its recent share price falls, highly acquisitive Spanish laboratory diagnostic group Atrys Health is to buy Bienzobas for €76.3m, a Spanish company which provides oncology services to insurance companies and hospital groups.
Operose Health, one of the biggest GP providers to the UK NHS, is facing an accusation of mismanagement at one of its surgeries by an undercover BBC Panorama investigation. It blames a national lack of GPs.
The UK government has launched a new strategy for the use of digital technology and data in the health and social care sectors. Health secretary Sajid Javid gave a speech at the HealthTech Summit in London on the day of the launch about how the strategy will shake up the sector.
Listed British PE firm Bridgepoint’s planned acquisition of Dentego, France’s largest dentistry group, has fallen through due to disagreements with the vendor over the price.
Al Borg Diagnostics with 64 labs across 8 countries in GCC and Africa and a dominant position in Saudi Arabia, its home market, looks set to finally list in 2022. We speculate (wildly!) on valuation.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
